MLM Medical Labs

MLM Medical Labs is a global specialty and central laboratory supporting disease-agnostic research with extensive biomarker expertise. With harmonized laboratories in Europe, North America, and Africa, MLM operates across 90+ countries and five continents, supporting 300+ active clinical trials. Its portfolio includes more than 1,500 biomarker and assay parameters. As an IVDR-aligned health institution, MLM develops and validates Laboratory Developed Tests(LDTs) to advance clinical research. In November 2025, MLM became the first to successfully validate and implement the Lumipulse® G pTau217/Beta-Amyloid 1-42 Plasma Ratio assay as an LDT for clinical trials. This fully validated, ready-to-use blood-based biomarker enables participant inclusion and exclusion in Alzheimer’s studies across the U.S. and Europe.

For more information, please visit www.mlm-labs.com

Contact

Contact Persons:

Dr. Domenik Liße, Business Development Manager,
Domenik.lisse@mlm-labs.com

Annette Angenendt, Marketing Manager,
aangenendt@mlm-labs.com